Basso Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Basso Capital Management's BMY Position: Q2 2026 in Review
Basso Capital Management increased its Bristol-Myers Squibb (BMY) stake by 131% in Q2 2026, buying an estimated $119K and bringing the position to 3,656 shares worth $211K. The position accounts for 0.04% of the portfolio, ranked #135.
Basso Capital Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Basso Capital Management held 3,656 shares of Bristol-Myers Squibb worth $211K as of Q2 2026.
- Basso Capital Management bought 2,072 Bristol-Myers Squibb shares in Q2 2026, an estimated $119K.
- Bristol-Myers Squibb made up 0.04% of Basso Capital Management's portfolio in Q2 2026, its #135 holding.
- Basso Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Basso Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.